Administrative Core

行政核心

• 批准号: 10513914
• 负责人: David S Perlin
• 金额: $ 755.88万
• 依托单位: HACKENSACK UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-16 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10513914
• 关键词: 2019-nCoV; Academia; Address; Agreement; Antiviral Agents; Biotechnology; Businesses; Decision Making; Development; Ensure; Fostering; Goals; Health; Healthcare Systems; Individual; Industry; Institution; Intellectual Property; Investigational Drugs; Lead; Leadership; Licensing; Logistics; Mediation; Medicine; Mentors; Meridians; National Institute of Allergy and Infectious Disease; New Jersey; Online Systems; Outcome; Output; Performance; Pharmaceutical Chemistry; Pharmacology; Press Releases; Process; Progress Reports; Publications; Reporting; Research; Research Project Grants; Resource Allocation; Resources; Rice; Rights; Risk; Schedule; Secure; Site Visit; Structure; Time; Travel; United States National Institutes of Health; Virus; antiviral drug development; base; conflict resolution; data sharing; design; drug development; drug discovery; experience; industry partner; innovation; material transfer agreement; meetings; member; metropolitan; organizational structure; pandemic disease; pre-clinical; preclinical development; programs; success; virology

The MAVDA Administrative Core (MAC) will be established as an integrated, priority-setting consortium involving the Program Directors (PDs), a Business Director (BD), an internal MAVDA Leadership Team (MLT), and a Scientific Advisory Board (SAB) with programmatic involvement from NIAID to enhance potential product outcome in the form of antivirals against SAR-CoV-2 and other viruses with pandemic potential. The management function is designed to provide administrative support that facilitates the success of individual projects, promotes effective integration and allocation of support functions and resources, and stimulates scientific exchange between MAVDA members, thus ensuring that the overall program achieves its objectives. The MAC will be overseen by co-PDs, Dr. David S. Perlin and Dr. Charles M. Rice, who will be supported by an experienced BD and appropriate support staff to coordinate and manage all administrative functions. To best advance MAVDA's objectives, the MAC will coordinate regular meetings of Project Leaders, Pharma/Biotech Partners, Core Directors, and SAB members. The meetings are designed to advance compounds through the discovery matrix enabling timely and objective ‘Go/No Go’ decision making. A secure web-based platform will be used to foster interactions between Projects and Cores. The MAC will facilitate an annual review meeting with the SAB, and a reverse site visit at NIAID. It will produce and submit the annual progress report to the NIH, and it will coordinate research publications, meeting presentations, reports and press releases. MAVDA is designed to encourage partnering among academia and industry, specifically Pharma and Biotech companies, and has protections in place to protect the intellectual property of participating organizations. There is universal confidentiality between projects and cores, with data shared as required to advance compounds and at no risk to the project team. As MAVDA retains no IP rights, all IP rights reside in the host institutions or per agreements with industry partners. The MAC will execute the following Specific Aims: 1) establish a highly efficient management structure that supplies essential oversight and guidance for Project Leaders and Core Directors, effectively integrates the Scientific Advisory Board as strategic advisors in the discovery process, and promotes scientific exchange; 2) maximize allocation of resources and prioritize compound development by establishing critical metrics for ‘Go/No Go’ decision making and resource allocations by supporting close interactions of Project Leaders and Core Directors and scheduling regular reviews; 3) annually assess project performance and prepare interim and year-end reports; 4) solicit and manage Developmental and Mentored Research Projects; 5) coordinate publications, presentations of results, and press releases from these studies and develop a managerial plan for conflict resolution and other operational issues; and 6) establish an internal organizational structure that addresses logistics for material transfer agreements, intellectual property filings, licensing opportunities, and negotiations.

MAVDA行政核心（MAC）将作为一个综合的、确定优先事项的联合体建立